Prevention.com—May 11, 2012
A new FDA study finds that taking anti-bone-loss drugs like Fosamax long-term isnít all itís cracked up to be.
ďThere is clear evidence that these drugs reduce the risk of spinal and hip fractures,Ē says Linda A. Russell, M.D., a rheumatologist at Hospital for Special Surgery. ďBut when a patient has been on the drug for 3-5 years, you have to look at whether they still need it, or if they should take a holiday.Ē
Read the full story at Prevention.com.